Nanoparticle-Protein Corona Boosted Cancer Diagnosis with Proteomic Transfer Learning

Area of Science:

• Proteomics
• Bioinformatics
• Machine Learning in Oncology

Background:

• Multiproteomic data integration is crucial for advancing cancer biomarker identification and diagnosis.
• Significant challenges exist in integrating diverse proteomic datasets due to variability and wide protein expression ranges.

Purpose of the Study:

• To develop a novel method for integrating multiproteomic data to enhance bladder cancer diagnosis and progression monitoring.
• To establish paired serum and urine proteome databases for comprehensive analysis.

Main Methods:

• Creation of two in-depth paired proteome databases (956 serum, 4730 urine proteins).
• Development of a proteomic-based transfer learning neural network (ProteoTransNet) for data integration.
• Application of random forest analysis to identify key protein panels.

Main Results:

• ProteoTransNet successfully integrated serum and urine proteome data, minimizing biases and errors.
• Two panels of top 10 key proteins achieved high diagnostic performance: AUC of 0.996 for diagnosis and 0.914 for stage classification.
• The integrated approach significantly enhanced diagnostic accuracy for bladder cancer.

Conclusions:

• Transfer learning applied to biological data offers a powerful approach to address complex challenges in disease diagnosis and prognosis.
• ProteoTransNet demonstrates the potential of sophisticated biological information transfer learning for improving clinical outcomes in oncology.
• This study provides a robust framework for multiproteomic data integration in cancer research.